Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Goodwill (2016 - 2024)

Tg Therapeutics has reported Goodwill over the past 9 years, most recently at $799000.0 for Q1 2024.

  • Quarterly results put Goodwill at $799000.0 for Q1 2024, changed 0.0% from a year ago — trailing twelve months through Mar 2024 was $799000.0 (changed 0.0% YoY), and the annual figure for FY2023 was $799000.0, changed 0.0%.
  • Goodwill for Q1 2024 was $799000.0 at Tg Therapeutics, roughly flat from $799000.0 in the prior quarter.
  • Over the last five years, Goodwill for TGTX hit a ceiling of $799000.0 in Q1 2020 and a floor of $799000.0 in Q1 2020.
  • Median Goodwill over the past 5 years was $799000.0 (2020), compared with a mean of $799000.0.
  • Peak annual rise in Goodwill hit 0.0% in 2020, while the deepest fall reached 0.0% in 2020.
  • Tg Therapeutics' Goodwill stood at $799000.0 in 2020, then changed by 0.0% to $799000.0 in 2021, then changed by 0.0% to $799000.0 in 2022, then changed by 0.0% to $799000.0 in 2023, then changed by 0.0% to $799000.0 in 2024.
  • The last three reported values for Goodwill were $799000.0 (Q1 2024), $799000.0 (Q4 2023), and $799000.0 (Q3 2023) per Business Quant data.